NYSE:MD
Mednax Inc Stock News
$8.17
-0.330 (-3.88%)
At Close: May 09, 2024
Credit Suisse Maintains Outperform on Mednax, Raises Price Target to $24
12:53pm, Monday, 08'th Jun 2020Why Is Mednax (MD) Up 46.5% Since Last Earnings Report?
03:31pm, Saturday, 06'th Jun 2020
Mednax (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MEDNAX Intends To Sell MEDNAX Radiology Solutions Unit; Has Repaid Revolving Credit Line
10:52am, Friday, 05'th Jun 2020MEDNAX Says Will Return To Original Name, Pediatrix Medical Group, Will Refocus On Pediatrics, Obstetrics
10:52am, Friday, 05'th Jun 2020MEDNAX Announces Significant Progress in Strategic Transformation
10:50am, Friday, 05'th Jun 2020
MEDNAX Announces Significant Progress in Strategic Transformation
MEDNAX Announces Significant Progress in Strategic Transformation
12:00am, Friday, 05'th Jun 2020
MEDNAX Announces Significant Progress in Strategic Transformation
MEDNAX Business Update Conference Call/Webcast Scheduled for Friday, June 5, 2020
08:15pm, Monday, 01'st Jun 2020
MEDNAX Business Update Conference Call/Webcast Scheduled for Friday, June 5, 2020
Why Should You Hold on to Tenet Healthcare (THC) Stock?
02:02pm, Friday, 29'th May 2020
Despite the recent drag in Tenet Healthcare's (THC) business volumes, the same is expected to bounce back, given its solid fundamentals and the strategic initiatives taken.
MEDNAX Plunges More Than 42% YTD: Will the Stock Rebound?
04:14pm, Wednesday, 27'th May 2020
Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.
Anterix and Bausch Holding See Activist Action
11:00pm, Friday, 22'nd May 2020
Owl Creek Asset Management increased its stake in wireless-communications firm Anterix, while Paulson & Co. bought more Bausch stock.
2 Stocks to Short and 1 to Buy, According to a Short-Selling Maven
12:56pm, Friday, 22'nd May 2020
Mark Roberts of Off Wall Street has been advising hedge funds for 30 years. Why he’s bearish on a software firm and a lubricants maker—and bullish on a gold stock.
2 Stocks to Shun and 1 to Buy, According to a Short-Selling Maven
01:58am, Friday, 22'nd May 2020
Mark Roberts of Off Wall Street has been advising hedge funds for 30 years. Why he’s bearish on a software firm and a lubricants maker—and bullish on a gold stock.
SunTrust Robinson Humphrey Maintains Hold on Mednax, Raises Price Target to $17
01:02pm, Thursday, 21'st May 2020EBITDA = 'BS Earnings' - Magic Formula Underperformance, Part II
01:29pm, Wednesday, 20'th May 2020
Joel Greenblatt’s “Magic Formula” strategy of buying quality companies at a discount has outperformed over time. The strategy had an excellent run in the 2000s,
